A rapid increase in circulating IGF-1 from below the normal range to the upper normal range [13,14] may contribute to the formation of oedema in general, and to cerebral oedema during DKA treatment, which is consistent with previous reports [4-6]. The gene discussed is IGF1; the disease is brain edema.